Parkinson's Disease and Neuropsychological Assessment

International Journal of Neuroscience

Volumn 99, Issue 42008, 1999, Pages 1-18

  Ridenour, T Andrew ^a   Dean, Raymond S ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BALL STATE UNIVERSITY   (United States)

Author keywords

etiology; literature review; neuropsychological assessment; Parkinson' disease

Indexed keywords

EID: 0033180058     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207459908994310     Document Type: Article

References (108)

1. Barbeau A. Etiology of Parkinson's disease: A research strategy. Canadian Journal of Neurological Science 1984; 24: 24 – 28
2. Baumann R. J., Jameson H. D., McKcan H. E., Haack D. G., Weisberg L. M. Cigarette smoking and Parkinson's disease: A comparison with matched neighbors. Neurology 1980; 30: 839 – 843
3. Becker J. B., Robinson T. E., Barton P., Sintov A., Rivka S., Levy R. J. Sustained behavioral recovery from unilateral nigrostriatal damage produced by the controlled 1990
4. Bernheimer H., Birkmayer W., Hornykicwcz O., Jellinger K., Geitelberger F. Genetic susceptibility, environmental factors and Parkinson's disease. Paper presented at the VIIth International Symposium on Parkinson's Disease. 1985
5. Bernheimer H., Birkmayer W., Hornykicwcz O., Jellinger K., Geitelberger F. Brain dopamine and the syndroms of Parkinson and Huntington. Journal of Neurological science 1973; 20: 455
6. Bharucha N. E., Stokes L., Schoenberg B. S., Ward C., Ince S., Nutt J. G., Eldridge R., Calne D. B., Mantel N., Duvoisin K. A case-control study of twin pairs discordant for Parkinson's disease: A search for environmental risk factors. Neurology 1986; 36: 284 – 288
7. Bodis-Wollner I. Visual deficits related to dopamine deficiency in experimental animals and Parkinson's disease patients. Trends in Neurosciences 1990; 37: 296 – 302
8. Bodis-Wollner I., Yahr M. D., Mylin I., Thornton J. Dopaminergic dcficieny and delayed visual evoked potentials in humans. Annals of Neurology 1982; 11: 478 – 483
9. Bodis-Wollner I., Harnois C., Robak P., Mylin L. On the possible role of temporal delays of afferent processing in Parkinson's disease. Journal of Neural Transmission 1983; 19: 243 – 252
10. Boller F., Passafiume D., Keefe N. C., Rogers K., Morrow L., Kim Y. Visuospatial impairment in Parkinson's disease. Archives of Neurology 1984; 41: 485 – 490
11. Botez M. I., Barbeau A. Neuropsychological findings in Parkinson's disease: A comparison between various tests during long-term levodopa therapy. International Journal of Neurology 1975; 10: 222 – 232
12. Bowen F., Burns M., Brady E., Yahr M. Parkinsonism: Effects of levodopa treatment on concept formation. Neurology 1975; 25: 701 – 704
13. Bowen F., Yahr M. Behavioral alterations in patients with basal ganglia lesions. The basal ganglia, M. Yahr. Raven Press, New York 1976; 169 – 180
14. Brown R. G., Marsden C. D. Internal versus external cues and the control of attention in Parkinson's disease. Brain 1988; 111: 323 – 345
15. Brown R. G., Marsden C. D. Visuospatial function in Parkinson's disease. Brain 1986; 109: 987 – 1002
16. Burke W. J., Peterson J., Rubin E. H. Electoconvulsive therapy in the treatment of combined depression and Parkinson's disease. Psychosomatics 1988; 29 (2) 341 – 345
17. Burns R. B., Chiueh C. C., Markey S. P., Ebert M. H., Jacobowitx D. M., Kopin J. A primate model of parkinsonism: selective destruction of dopaminerpic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1. 2,3, 6-tetrahydropyridine 1983
18. Carlsson A., Lindquist M., Tagnusson T. 3,4-dihydroxyphenylalanine and 5-Hydroxytryptophan as reserpine antagonists. Nuture 1957; 180: 1200
19. Carlson N. R. Foundations of physiological psychology. Allyn and Bacon. Inc, Boston 1988
20. Cools A., Van den Berken J., Horstinek M., Van Spaendonek K., Berger H. Cognitive and motor shifting aptitude in Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry 1984; 47: 443 – 453
21. Cummings J. L., Benson F. Subcortical dementia. Archives of Neurology 1984; 41: 874 – 879
22. Cummings J. L., Benson F. Psychological dysfunction accompanying subcortical denientias. Annual Review of Medicine 1988; 39: 53 – 61
23. Delwaide P. J., Gonce M. Pathophysiology of Parkinson's signs. Parkinson's disease and movement disorders, J. Jankovic, E. Tolosa. Urban and Schwarzenburg, Baltimore 1988; 59 – 74
24. Della Sala S., DiLorenzo G., Giordana A., Spinnler H. Directional forecast: A specific visuo-spatial impairment of parkinsonians. Journal of Neurology, Neurosurgery, and Psychiatry 1986; 49: 1258 – 1265
25. Direnfeld L., Albert M., Volicer L., Langlais P., Marquis J., Kaplan E. Parkinson's disease: The possible relationship of laterality to dementia and neurochemical findings. Archives of Neurology 1984; 41: 935 – 941
26. Duvoisin R. C. Parkinson's disease: A guide for patient and family. Raven Press, New York 1991
27. Duvoisin R. C., Gearing F. R., Schweitzer M. D., Yahr M. D. A family study of parkinsonism. Progress in Neurogenetics, A. Barbeau, J. R. Brunette. Excerpta Medica, Amsterdam 1969; 492 – 496
28. Evarts E. V., Teravainen H., Calne D. B. Reaction time in Parkinson's disease. Brain 1981; 104: 167 – 186
29. Fahn S., Tolosa E., Marin C. Clinical rating scale for tremor. Parkinson's disease an movement disorders, J. Jankovic, E. Tolosa. Urban and Schwarzenburg, Baltimore 1988; 225 – 234
30. Folstein M. F., Folsein S. E., McHugh P. R. “Mini-Mental State”: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Reaserch 1975; 12: 189 – 198
31. Gaudin D. P., Rioux L., Bedard P. J. Fetal Da neuron transplants prevent behavioral supersensitivity induced by repeated administration of L-DOPA in the rat. Brain Research 1990; 506 (1) 166 – 168
32. Gelenberg A. J., Bassuk E. L., Schoonover S. C. The practioner's guide to psychoactive drugs (3rd ed.). Plenum Medical Book Company, New York, NY 1991
33. Gershanik O. S. Parkinsonism of early onset. Parkinson's disease and movement disorders, J. Jankovic, E. Tolosa. Urban and Schwarzenburg, Baltimore 1988; 191 – 204
34. Gibb W. R. The neuropathology of parkisonian disorders. Parkinson's and movement disorders, J. Jankovic, E. Tolosa. Urban and Schwarzenburg, Baltimore 1988; 205 – 224
35. Godwin-Austen R. B., Lee P. N., Marmot M. G., Stern G. M. Smoking and Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry 1982; 45: 577 – 581
36. Golbe L. I., Duvoisin R. C. The epidemiology of and natural history of Parkinson's disease. The comprehensive management of Parkinson's disease, M. B. Stern, H. I. Hurtig. PMA Publishing Corp, New York 1988; 51 – 62
37. Gotham A. M., Brown R. G., Marsden C. D. “Frontal” cognitive function in patients with Parkinson's disease “on” and “off” levodopa. Brain 1988; 111: 299 – 321
38. Grimes J. D., Hassan M. N., Preston D. N. Adverse neurologic effects of metaclopramide. Canadian Medical Association Journal 1982; 126: 23 – 52
39. Gronwall D. Paced auditory serial addition task: A measure of recovery from concussion. Perceptual and Motar Skills 1977; 44: 367 – 373
40. Hardie R. J. Problems and unanswered questions concerning levodopa treatment in Parkinson's disease. Acta Neurologica-Scandinavia 1989; 80 (126) 77 – 82
41. Hardie R. J., Lees A. J. Neuroleptic-induced Parkinson's syndrome: Clinical features and results of treatment with levodopa. Journal of Neurology, Neurosurgery and Psychiatry 1988; 51 (6) 433 – 446
42. Heinonen E. H., Rinne U. K. Selegiline in the treatment of Parkinson's Disease. Acta Neurologica-Scandinavia 1989; 80 (126) 103 – 111
43. Hietanen M., Teravainen H. Cognitive performance in early Parkinson's disease. Acta Neurologica Scandinavica 1986; 73: 151 – 159
44. Hovestadt A., De Jong G. J., Meerwaldt J. D. Spatial disorientation as an early symptom of Parkinson's disease. Neurology 1987; 37: 485 – 487
45. Huber S. J., Shulman H. G., Paulson G. W., Shuttleworth E. C. Dose-dependent memory impairment in Parkinson's disease. Neurology 1989; 39: 438 – 440
46. Huber S. J., Shuttleworth K. C., Paulson G. W. Dementia in Parkinson's disease. Archives of Neurology 1986; 43: 987 – 990
47. Hutton J. T., Dippel R. L. Caring for the Parkinson patient. Prometheus Books, Buffalo 1989
48. Irwin I., Langston J. W., DeLanney I. E. 4-phenylpyridine (4PP) and MPTP: The relationship between striatal MPP- concentrations and neurotoxicity. Life Sciences 1987; 40: 731 – 740
49. Jankovic J., Marsden C. D. Therapeutic strategies in Parkinson's Disease. Parkinson's disease and movement disorders, J. Jankovic, E. Tolosa. Urban and Schwarzenburg, Baltimaore 1988; 95 – 120
50. Jankovic J., Tolosa E. Parkinson's disease and movement disorders. Urban and Schwarzenburg, Baltimore 1988
51. Jenner P., Marsden C. D. MPTP-induced parkinsonism as an experimental model of Parkinson's disease. Parkinson's disease and movement disorders, J. Jankovic, E. Tolosa. Urban and Schwarzenburg, Baltimore 1988; 37 – 48
52. Karayandis F. Parkinson's disease: A conceptualization of neuropsychological deficits within an information-processing framework. Biological Psychology 1989; 29: 149 – 179
53. Kaufman A. S. Intelligence testing with the WISC-R. John Wile & Sons. Inc, New York, NY 1979
54. Klawans H. L., Stein R. W., Tanner C. M., Goetz C. G. A pure parkinsonian syndrome following acute carbon monoxide intoxication. Archives of Neurology 1982; 39: 302
55. Lang A. E. The genetics of Parkinson's disease. Handbook of Parkinson's disease, F. S. Livingston. Marcel Dekker, New York 1987
56. Langston J. W. The etiology of Parkinson's disease: New directions for research. Parkinson's disease and movement disorders, J. Jankovic, E. Tolosa. Urban and Schwarzenburg, Baltimore 1988; 75 – 86
57. Lees A., Smith E. Cognitive deficits in the early stages of Parkinson's disease. Brain 1983; 106: 257 – 270
58. Lewin R. Parkinson's disease: An environmental cause. Science 1985; 229: 979 – 980
59. Lewy F. H. Neurological, medical and biochemical signs and symptoms indicating chronic industrial carbon disulphide absorption. Annuals of International Medicine 1941; 15: 869 – 883
60. Lieberman A. N. Update on Parkinson's disease. New York Stale Journal of Medicine 1987; 87 (3) 147 – 153
61. Marsden C. D. Defects of movement in Parkinson's disease. Restorative Neurology, 2, Clinical Neurophysiology in Parkinsonism, Declwaide, Agnoli, 1985; 107 – 115
62. Marttila R. J., Kaprio J., Koshenvuo M., Rinne U. K. Finnish Parkinson's disease twin study: Preliminary results. Upsula Journal of Medical Science 1986; 43: 93
63. Mattis S. Mental status examination for organic mental syndrome in the elderly patient. Geriatric psychiatry, L. Bellak, T. Karasu. Grune and Stratton, New York 1976; 77 – 121
64. Mayeux R. The psychiatric and sexual complications of Parkinson's disense. Medical Aspects of Human Sexuality 1987; 21 (3) 68 – 72
65. Mortimer J. A., Pirozzolo F. J., Hansch E. C., Webster. Relationship of motor symptoms to the intellectual deficits in Parkinson's disease. Neurology 1982; 32: 133 – 137
66. Nissenbaum H., Quinn N. P., Brown K. G., Toone B. K., Gotham A. M., Marsden C. D. Mood swings associated with the “on-olf” phenomenon in Parkinson's disease. Psychological Medicine 1987; 17 (4) 899 – 904
67. Ogawa T. Personality characteristics of Parkinson's disease. Perception and Motor Skills 1981; 52: 375 – 378
68. Ostergaard K., Dupont E. Slozapine treatment of drug-induced psychotic symptoms in late stages of Parkinson's disease. Acta Neurologiaca-Scandinavia 1988; 78 (4) 349 – 350
69. Parkinson J. Essay on the shaking palsy. Sherwood. Neely, and Jones, London 1817
70. Peters H. A., Levine R. L., Matthews C. J., Chapman L. J. Extrapyramidal symptoms from carbon disulphide exposure in grain storage workers. Neurology 1981; 36: 342
71. Pierce J. R. Living with Parkinson's disease. Spectrum Communications, Knoxville, Tenn 1989
72. Pillon B., Dubois B., Lhermitte F., Agid Y. Heterogencity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer's disease. Neurology 1986; 36: 1179 – 1185
73. Pillon B., Dubois B., Bonnet A. M., Esteguy M., Guimataes J., Vigouret J. M., Lhermitte F., Agid Y. Cognitive slowing in Parkinson's disease fails to respond to levodopa treatment: The 15 objects test. Neurology 1989; 39: 762 – 768
74. Pitcairn T. K., Clemic S., John G. M., Pentland B. Non-verbal cues in the self-presentation of Parkinsonian patients. British Journal of Clinical Psychology 1990; 29 (2) 177 – 184
75. Poewe W., Gerstenbrand F., Ransmayr G., Plorer S. Premorbid personality of Parkinson patients. Journal of Neural Transmission 1983; 19: 215 – 242
76. Rafal R., Posner M., Walsker J., Friedrich F. Cognition and the basal ganglia. Brain 1984; 107: 1083 – 1094
77. Raskin S. A., Borod J. C., Tweedy J. Neuropsychological aspects of Parkinson's disease. Neuropsychology Review 1990; 1 (3) 185 – 221
78. Rajput A. H., Offord K. P., Beard C. M., Durland L. T. Annals of Neurology 1984; 16: 278 – 282
79. Rajput A. H., Stern W., Christ A., Laverty W. Etiology of Parkinson's disease: Environmental Fector(s). Neurology 1984; 34: 207
80. Reitan K., Boll T. Intellectual and cognitive functions in Parkinson's disease. Journal of Consulting and Clinical Psychology 1971; 37: 364 – 369
81. Riederer P., Wutctich S. Time course of nigrostriatal degeneration in Parkinson's disease. Jouranl of Neural Transmission 1976; 38: 277 – 301
82. Rinne U. K. Problems associated with long-term levodopa treatment of Parkinson's disease. Acta Neurologica Scandinavia 1983; 68: 19 – 26
83. Rinne U. K., Sonninen V. Acid monamine metabolites in the cerebral spinal fluid of patients with Parkinson's disease. Neurology 1972; 22: 62 – 69
84. Rinne J. O., Rummukainen J., Paljarvi L., Rinne U. K. Dementia in Parkinson's disease is related to neuronal loss in the medial SN. Annals of Neurology 1989; 26 (1) 47 – 50
85. Roy M., Boyer L., Barbeau A. A prospective study of 50 cases of familial Parkinson's disease. Canadian Journal of Neurological Science 1983; 10: 37 – 42
86. Sahakian B. J., Morris R. G., Evenden J. L., Heald A., Levy R., Philpot M., Robbins T. W. A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson's disease. Brain 1988; 111: 695 – 718
87. Scholz O. B., Sastry M. Memory characteristics in Parkinson's disease. International Journal of Neuroscience 1985; 27: 229 – 234
88. Schultz W. Recent physiological and pathophysiological aspects of parkinsonian movement disorders. Life Sciences 1984; 34 (23) 2213 – 2223
89. Silver J. M., Hales R. H., Yudofsky S. C. Psychoparmacology of depression in neutologic disorders. Paper presented at the 142nd. Annual Meeting of the American Psychiatric Association 1990; 51: 33 – 39, suppl
90. Starkstein S., Leiguarda R., Gershan O., Berthier M. Neuropsychological disturbance in hemiparkinson's disease. Neurology 1987; 37: 1762 – 1764
91. Stein M. B., Heuser I. J., Juncos J. L., Thomas W. U. Anxiety disorders in patients with Parkinson's disease. American Journal of Psychiatry 1990; 147 (2) 217 – 220
92. Stern M. B. The clinical characteristics of Parkinson's disease and parkinsonian syndroms: Diagnosis and assessment. The comprehensive management of Parkinson's disease, M. B. Stern, H. I. Hurtig. PMA Publishing Corp, New York 1988; 3 – 50
93. Stern M. B., Hurtig H. I. The comprehensive management of Parkinson's disease. PMA Publishing Corp, New York 1988
94. Stern G., Lees A. J. Parkinson's disease. The facts. Oxford University Press, New York 1990
95. Stern Y., Sano M., Mayeux R. Comparisons of dementia and intellectual change in Parkinson's and Alzheimer's disease. Journal of Clinical and Experimental Neuropsychology 1987; 9: 66
96. Sluss D., Benson D. F. The frontal lobes. Raven, New York 1986
97. Tanner C. M. Influence of environmental factors on the onset of Parkinson's disease. Neurology 1986; 36: 215
98. Taylor A. F., Saint-Cyr J. A., Lang A. E. Parkinson's disease: Cognitive changes in relation to treatment response. Brain 1987; 110: 35 – 51
99. Taylor A. F., Saint-Cyr J. A., Lang A. F. Frontal lobe dysfunction in Parkinson's disease: The cortical focus of neostriatal outflow. Brain 1986; 109: 845 – 883
100. Tweedy J. R., Langer K. G., McDowell F. H. The effect of semantic relations on the memory deficit associated with Parkinson's disease. Journal of Clinical Neuropsychology 1982; 4: 235 – 247
101. Lopp B. Toward a better understanding of Parkinson's disease. Geriatric Nursing 1987; 8 (4) 180 – 182
102. Litti R. J., Rajput A. H., Ashenburst E. M., Rosdilsky B. Cyanide-induced parkinsonism: A clinicopathologic report. Neurology 1985; 35: 921 – 925
103. Ward C. D. Soes selegiline delay progression of Parkinson's disease? A critical re-evaluation of the DATATOP study. Journal of Neurology, Neurosurgery, and Psychiatry 1994; 57 (2) 217 – 220
104. Ward C. D., Duvoisin R. C., Ince S. E., Nutt J. D., Eldridge R., Calne D. B. Parkinson's disease in 65 pairs of twins and in a set of quadruplets. Neurology 1983; 33: 815 – 824
105. Weingartner H., Burns S., Diebel R., LeWitt P. Cognitive impairments in Parkinson's disease: Distinguishing between effort-demanding and qutomatic cognitive processes. Psychiatric Research 1984; 11: 223 – 235
106. Whitehouse P. J., Price D. I., Struble R. G., Clark A. W., Coyle J. T., DeLong M. R. Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain. Science 1982; 215: 1237 – 1239
107. Yochoki M. Juvenile Parkinson's disease: Clinical aspects. Advanes in Neurological Sciences 1979; 23: 1048 – 1059
108. Yochoki M., Narabyasli H. Clinical aspects of juvenile parkinsonism. Research progress in Parkinson's disease, F. C. Rose, R. Capildea. Pitman, Turnbridge Wells 1981; 35 – 39